Genome-Scale CRISPR-Cas9 Knockout Screening in Gastrointestinal Stromal Tumor With Imatinib Resistance

Molecular Cancer - United Kingdom
doi 10.1186/s12943-018-0865-2
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Screening Genes Promoting Exit From Naive Pluripotency Based on Genome-Scale CRISPR-Cas9 Knockout

Stem Cells International
Cell BiologyMolecular Biology
2020English

RACK1 Overexpression Is Linked to Acquired Imatinib Resistance in Gastrointestinal Stromal Tumor

Oncotarget
Oncology
2016English

Severe Esophagitis in a Patient With Gastrointestinal Stromal Tumor Treated With Imatinib

Endoscopy
Gastroenterology
2009English

Imatinib Induced Severe Skin Reactions and Neutropenia in a Patient With Gastrointestinal Stromal Tumor

BMC Cancer
Cancer ResearchOncologyGenetics
2010English

Imatinib-Induced Hepatitis Treated by Corticosteroids in a Patient With Metastatic Gastrointestinal Stromal Tumor

Yeungnam University Journal of Medicine
2019English

Establishment of an miR‑137‑knockout Cell Model Using CRISPR/Cas9 Genome Editing

Oncology Letters
Cancer ResearchOncology
2018English

Genome-Wide CRISPR/Cas9 Library Screening Identified PHGDH as a Critical Driver for Sorafenib Resistance in HCC

Nature Communications
AstronomyGeneticsMolecular BiologyBiochemistryChemistryPhysics
2019English

Genome‐Wide CRISPR‐Cas9 Screening Identifies NF‐κB/E2F6 Responsible for EGFRvIII‐Associated Temozolomide Resistance in Glioblastoma

Advanced Science
Materials ScienceGeneticsMolecular BiologyBiochemistryEngineeringChemical EngineeringMedicineAstronomyPhysics
2019English

Efficient Gene Knockout in Goats Using CRISPR/Cas9 System

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy